Arkolith/Insider Trading/OCUL/Form 4

Dugel Pravin

See Remarks, DirectorOCULAR THERAPEUTIX, INC (OCUL) · full profile →Form 4 · filed Sep 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 9, 2025Gift(G)50K—$03.2M
Sep 9, 2025Gift(G)50K—$050K

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001410578-25-002028) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML